The Fraudulent Dr Fauci – Part II: The Remdesivir Scam

Share this:

In April, 2020, Anthony Fauci cited a study which he said proved Remdesivir could block coronavirus.

He claimed the study showed Remdesivir was safe and efficacious in the use against the Ebola virus, in both 2018 and 2019, but this was a lie. If one were to actually look at the study, titled; ‘A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics‘, which was testing four different drugs against the Ebola virus, they will find that the safety board pulled Remdesivir out of trial six months early, because over 50% of patients who received it died.

Table 2. Comparison of Death at 28 Days According to Treatment Group.

Fauci quoted a second study in support of his mandating the use of Remdesivir, a study conducted by the makers of Remdesivir titled; ‘Compassionate Use of Remdesivir for Patients with Severe Covid-19‘, wherein 53 patients with covid were administered the drug for 10 days. 23% of them suffered from multiple organ disfunction syndrome, septic shock, and acute kidney injury. 8% of them had to be taken off the drug after only 5 days because it was killing them.

In February, 2020, a state-run Chinese lab sought a patent on the use of Remdesivir to treat coronavirus, based on the results of a single patient. After the CCP and Fauci recommended the use of Remdesivir, the U.S. secured the world’s supply, and began treating Americans with it. COVID patients immediately began suffering kidney failure, which was then blamed on covid, even though studies by the manufacture show Remdesivir causes it in 23% even after only a few days.

When the kidneys fail the lungs fill with liquid, which is how thousands have died in the hospitals, being put on ventilators, and it’s all being blamed on covid. But if we read the fine print, we can see that all this is to be expected with Remdesivir. And Fauci knows it. They sew fear with mainstream media pop-culture lies, and kill us with deadly drugs and hospitals.

Gilead Sciences, the biblically-named ‘cash register’ pharma company with a long history, and who make Remdesivir, said it will charge the US government $390 per vial for its virus drug Remdesivir. That’s over $2,300 dollars for a typical five-day treatment. Per person.
The longer 10-day treatment course will cost governments $4,290 per patient, and $5,720 for a US patient with private insurance.

A study, conducted by the Center for Integration of Science and Industry at Bentley University and posted on a preprint server, found the development of Remdesivir was supported by a whopping $6.5 billion dollars of tax payer’s money in funding for basic research by the National Institutes of Health (NIH) over several decades. Clearly an audit of Gilead Sciences is warranted, but in the current climate, there’s little hope of it ever being legitimate.

Rep. Lloyd Doggett, D-Texas, called the pricing on Remdesivir “outrageous.” “Without a taxpayer investment of $99 million, this drug [Remdesivr] would have been abandoned. It would be on the scrap heap of failures,” he told NPR.

In an offensive display of hubris and disregard for the public, Gilead has priced at several thousand dollars a drug that should be in the public domain,” Peter Maybarduk, director of Public Citizen’s Access to Medicines Program said in a written statement.

Analysts at Royal Bank of Canada forecast the drug could generate $2.3 billion in revenue 2020.

Remdesivir is just another in a long history of drugs approved solely for the purposes of reaping big profits for Fauci and the democidal cabal that he fronts, bilking the tax payer of billions, all while quietly euthanizing an unwitting public. Just like so the so-called “vaccines”, of which the FDA was fully aware of how deadly they are since at least October, 2020, proven by the accidental? split-second showing of a frame during an almost nine-hour video conference of a draft of a working list of all major side-effects. The frame, pictured below, can be seen for a brief moment at 2 hours, 33 minutes and 40 seconds [cued];


Share this:
Scroll to Top